Haemonetics Reports 3rd Quarter Fiscal 2016 Revenue of $233 Million, Constant Currency Revenue Growth of 4% and 1% As Reported

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. APGE
6. DFTX
7. GOOGL
8. MU
9. IBM
10. HOOD

Go back to Haemonetics Reports 3rd Quarter Fiscal 2016 Revenue of $233 Million, Constant Currency Revenue Growth of 4% and 1% As Reported

Haemonetics (HAE) Gains After EPS

February 1, 2016 9:47 AM EST

Haemonetics (NYSE: HAE) is seeing sharp upside following third quarter earnings this morning. Shares are up 6.7%.

Haemonetics reported Q3 EPS of $0.48, $0.02 better than the analyst estimate of $0.46. Revenue for the quarter came in at $233.4 million versus the consensus estimate of $237.37 million. Haemonetics also reaffirmed FY2016 guidance.

... More